An NIR-responsive and sugar-targeted polypeptide composite nanomedicine for intracellular cancer therapyElectronic supplementary information (ESI) available. See DOI: 10.1039/c4cc05983b

The upconversion nanoparticle (UCNP)-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy. The half maximal inhibitory concentration (IC 50 ) of the nanoparti...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu, Gang, Zhou, Linzhu, Su, Yue, Dong, Chang-Ming
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 12541
container_issue 83
container_start_page 12538
container_title
container_volume 5
creator Liu, Gang
Zhou, Linzhu
Su, Yue
Dong, Chang-Ming
description The upconversion nanoparticle (UCNP)-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy. The half maximal inhibitory concentration (IC 50 ) of the nanoparticles dropped 4.7-fold or 3.1-fold compared to non-targeted or non-irradiated counterparts. The UCNP-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy.
doi_str_mv 10.1039/c4cc05983b
format article
fullrecord <record><control><sourceid>rsc</sourceid><recordid>TN_cdi_rsc_primary_c4cc05983b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c4cc05983b</sourcerecordid><originalsourceid>FETCH-rsc_primary_c4cc05983b3</originalsourceid><addsrcrecordid>eNqFj8FKxDAQhoMouK5evAvjTQ9dW9Jq6020Yi8KrgdvZTaZrpE0CUl2oY_m2xlB8CDoXGbg_78PhrHjIl8UOW8uRClEXjU1X-2wWcEvy6wq69fdr7tqsiteVvvsIIT3PE1R1TP2cWPgsXvOPAVnTVBbAjQSwmaNPovo1xRJgrN6cuSikgTCjs4GFQkMGjuSVEIZgsF6UCZ6FKT1RqMHgUaQh_hGHt3UahLRW6NEkjunaSST_FOCEjpiVNbAWbvszgG3qDSuNC1gSQR3T901_H7wkO0NqAMdfe85O7lvX24fMh9E77wak7z_qfM5O_0r750c-H-OT1gicUk</addsrcrecordid><sourcetype>Enrichment Source</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>An NIR-responsive and sugar-targeted polypeptide composite nanomedicine for intracellular cancer therapyElectronic supplementary information (ESI) available. See DOI: 10.1039/c4cc05983b</title><source>Royal Society of Chemistry:Jisc Collections:Royal Society of Chemistry Read and Publish 2022-2024 (reading list)</source><creator>Liu, Gang ; Zhou, Linzhu ; Su, Yue ; Dong, Chang-Ming</creator><creatorcontrib>Liu, Gang ; Zhou, Linzhu ; Su, Yue ; Dong, Chang-Ming</creatorcontrib><description>The upconversion nanoparticle (UCNP)-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy. The half maximal inhibitory concentration (IC 50 ) of the nanoparticles dropped 4.7-fold or 3.1-fold compared to non-targeted or non-irradiated counterparts. The UCNP-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy.</description><identifier>ISSN: 1359-7345</identifier><identifier>EISSN: 1364-548X</identifier><identifier>DOI: 10.1039/c4cc05983b</identifier><language>eng</language><creationdate>2014-09</creationdate><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Liu, Gang</creatorcontrib><creatorcontrib>Zhou, Linzhu</creatorcontrib><creatorcontrib>Su, Yue</creatorcontrib><creatorcontrib>Dong, Chang-Ming</creatorcontrib><title>An NIR-responsive and sugar-targeted polypeptide composite nanomedicine for intracellular cancer therapyElectronic supplementary information (ESI) available. See DOI: 10.1039/c4cc05983b</title><description>The upconversion nanoparticle (UCNP)-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy. The half maximal inhibitory concentration (IC 50 ) of the nanoparticles dropped 4.7-fold or 3.1-fold compared to non-targeted or non-irradiated counterparts. The UCNP-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy.</description><issn>1359-7345</issn><issn>1364-548X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqFj8FKxDAQhoMouK5evAvjTQ9dW9Jq6020Yi8KrgdvZTaZrpE0CUl2oY_m2xlB8CDoXGbg_78PhrHjIl8UOW8uRClEXjU1X-2wWcEvy6wq69fdr7tqsiteVvvsIIT3PE1R1TP2cWPgsXvOPAVnTVBbAjQSwmaNPovo1xRJgrN6cuSikgTCjs4GFQkMGjuSVEIZgsF6UCZ6FKT1RqMHgUaQh_hGHt3UahLRW6NEkjunaSST_FOCEjpiVNbAWbvszgG3qDSuNC1gSQR3T901_H7wkO0NqAMdfe85O7lvX24fMh9E77wak7z_qfM5O_0r750c-H-OT1gicUk</recordid><startdate>20140918</startdate><enddate>20140918</enddate><creator>Liu, Gang</creator><creator>Zhou, Linzhu</creator><creator>Su, Yue</creator><creator>Dong, Chang-Ming</creator><scope/></search><sort><creationdate>20140918</creationdate><title>An NIR-responsive and sugar-targeted polypeptide composite nanomedicine for intracellular cancer therapyElectronic supplementary information (ESI) available. See DOI: 10.1039/c4cc05983b</title><author>Liu, Gang ; Zhou, Linzhu ; Su, Yue ; Dong, Chang-Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-rsc_primary_c4cc05983b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Gang</creatorcontrib><creatorcontrib>Zhou, Linzhu</creatorcontrib><creatorcontrib>Su, Yue</creatorcontrib><creatorcontrib>Dong, Chang-Ming</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Gang</au><au>Zhou, Linzhu</au><au>Su, Yue</au><au>Dong, Chang-Ming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An NIR-responsive and sugar-targeted polypeptide composite nanomedicine for intracellular cancer therapyElectronic supplementary information (ESI) available. See DOI: 10.1039/c4cc05983b</atitle><date>2014-09-18</date><risdate>2014</risdate><volume>5</volume><issue>83</issue><spage>12538</spage><epage>12541</epage><pages>12538-12541</pages><issn>1359-7345</issn><eissn>1364-548X</eissn><abstract>The upconversion nanoparticle (UCNP)-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy. The half maximal inhibitory concentration (IC 50 ) of the nanoparticles dropped 4.7-fold or 3.1-fold compared to non-targeted or non-irradiated counterparts. The UCNP-loaded polypeptide composite nanoparticles that present fast NIR-sensitivity and tunable sugar-targeting properties are fabricated, opening a new avenue for on-demand and targeted cancer therapy.</abstract><doi>10.1039/c4cc05983b</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1359-7345
ispartof
issn 1359-7345
1364-548X
language eng
recordid cdi_rsc_primary_c4cc05983b
source Royal Society of Chemistry:Jisc Collections:Royal Society of Chemistry Read and Publish 2022-2024 (reading list)
title An NIR-responsive and sugar-targeted polypeptide composite nanomedicine for intracellular cancer therapyElectronic supplementary information (ESI) available. See DOI: 10.1039/c4cc05983b
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A38%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-rsc&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20NIR-responsive%20and%20sugar-targeted%20polypeptide%20composite%20nanomedicine%20for%20intracellular%20cancer%20therapyElectronic%20supplementary%20information%20(ESI)%20available.%20See%20DOI:%2010.1039/c4cc05983b&rft.au=Liu,%20Gang&rft.date=2014-09-18&rft.volume=5&rft.issue=83&rft.spage=12538&rft.epage=12541&rft.pages=12538-12541&rft.issn=1359-7345&rft.eissn=1364-548X&rft_id=info:doi/10.1039/c4cc05983b&rft_dat=%3Crsc%3Ec4cc05983b%3C/rsc%3E%3Cgrp_id%3Ecdi_FETCH-rsc_primary_c4cc05983b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true